Effectiveness of BCG vaccination to aged mice
- PMID: 20809944
- PMCID: PMC2936867
- DOI: 10.1186/1742-4933-7-12
Effectiveness of BCG vaccination to aged mice
Abstract
Background: The tuberculosis (TB) still increases in the number of new cases, which is estimated to approach 10 million in 2010. The number of aged people has been growing all over the world. Ageing is one of risk factors in tuberculosis because of decreased immune responses in aged people. Mycobacterium bovis Bacillus Calmette Guérin (BCG) is a sole vaccine currently used for TB, however, the efficacy of BCG in adults is still a matter of debate. Emerging the multidrug resistant Mycobacterium tuberculosis (MDR-TB) make us to see the importance of vaccination against TB in new light. In this study, we evaluated the efficacy of BCG vaccination in aged mice.
Results: The Th1 responses, interferon-γ production and interleukin 2, in BCG inoculated aged mice (24-month-old) were comparable to those of young mice (4- to 6-week-old). The protection activity of BCG in aged mice against Mycobacterium tuberculosis H37Rv was also the same as young mice.
Conclusion: These findings suggest that vaccination in aged generation is still effective for protection against tuberculosis.
Figures


Similar articles
-
Reactivation of immune responses against Mycobacterium tuberculosis by boosting with the CpG oligomer in aged mice primarily vaccinated with Mycobacterium bovis BCG.Immun Ageing. 2013 Jun 22;10(1):25. doi: 10.1186/1742-4933-10-25. Immun Ageing. 2013. PMID: 23799936 Free PMC article.
-
Influence of advanced age on Mycobacterium bovis BCG vaccination in guinea pigs aerogenically infected with Mycobacterium tuberculosis.Clin Vaccine Immunol. 2010 Oct;17(10):1500-6. doi: 10.1128/CVI.00190-10. Epub 2010 Aug 4. Clin Vaccine Immunol. 2010. PMID: 20685935 Free PMC article.
-
Heterologous Boost Following Mycobacterium bovis BCG Reduces the Late Persistent, Rather Than the Early Stage of Intranasal Tuberculosis Challenge Infection.Front Immunol. 2018 Oct 30;9:2439. doi: 10.3389/fimmu.2018.02439. eCollection 2018. Front Immunol. 2018. PMID: 30425711 Free PMC article.
-
Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis?Vaccine. 2015 Sep 22;33(39):5035-41. doi: 10.1016/j.vaccine.2015.08.033. Epub 2015 Aug 28. Vaccine. 2015. PMID: 26319069 Free PMC article. Review.
-
Immune Responses to Bacillus Calmette-Guérin Vaccination: Why Do They Fail to Protect against Mycobacterium tuberculosis?Front Immunol. 2017 Apr 5;8:407. doi: 10.3389/fimmu.2017.00407. eCollection 2017. Front Immunol. 2017. PMID: 28424703 Free PMC article. Review.
Cited by
-
Immunomodulatory Effects of Adjuvants CPG, MPLA, and BCG on the Derp2-Induced Acute Asthma at Early Life in an Animal Model of BALB/c Mice.Inflammation. 2017 Feb;40(1):259-274. doi: 10.1007/s10753-016-0476-2. Inflammation. 2017. PMID: 27896542
-
Reactivation of immune responses against Mycobacterium tuberculosis by boosting with the CpG oligomer in aged mice primarily vaccinated with Mycobacterium bovis BCG.Immun Ageing. 2013 Jun 22;10(1):25. doi: 10.1186/1742-4933-10-25. Immun Ageing. 2013. PMID: 23799936 Free PMC article.
-
A prospective cross-sectional study of tuberculosis in elderly Hispanics reveals that BCG vaccination at birth is protective whereas diabetes is not a risk factor.PLoS One. 2021 Jul 29;16(7):e0255194. doi: 10.1371/journal.pone.0255194. eCollection 2021. PLoS One. 2021. PMID: 34324578 Free PMC article.
-
Importance of adjuvant selection in tuberculosis vaccine development: Exploring basic mechanisms and clinical implications.Vaccine X. 2023 Oct 29;15:100400. doi: 10.1016/j.jvacx.2023.100400. eCollection 2023 Dec. Vaccine X. 2023. PMID: 37965276 Free PMC article. Review.
-
Tuberculosis in an Aging World.Pathogens. 2022 Sep 26;11(10):1101. doi: 10.3390/pathogens11101101. Pathogens. 2022. PMID: 36297158 Free PMC article. Review.
References
-
- World Health Organization. World Health Prospect. World Health Organization, Geneva, Switzerland; 2008. http://esa.un.org/unpp/
-
- World Health Organization. Global tuberculosis control-surveillance, planning, financing. World Health Organization, Geneva, Switzerland; 2008.
-
- Brandt L, Feino CJ, Weinreich OA, Chilima B, Hirsch P, Appelberg R, Andersen P. Failure of Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis. Infect Immun. 2002;70:672–678. doi: 10.1128/IAI.70.2.672-678.2002. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Molecular Biology Databases